Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravesical”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03664869
What this trial is testing

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 300
Not applicableActive Not RecruitingNCT07693192
What this trial is testing

Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study

Who this might be right for
Overactive Bladder
Mahmoud Mohamed Farag Ali 60
Not applicableNot Yet RecruitingNCT07758881
What this trial is testing

Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Eight Medical International BV 30
Large-scale testing (Phase 3)Ended earlyNCT01410565
What this trial is testing

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 66
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Testing effectiveness (Phase 2)Looking for participantsNCT06637423
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 32
Large-scale testing (Phase 3)Looking for participantsNCT06319820
What this trial is testing

Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 641
Testing effectiveness (Phase 2)UnknownNCT03062059
What this trial is testing

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Who this might be right for
Urothelial Carcinoma
National Cancer Center, Korea 134
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Testing effectiveness (Phase 2)Study completedNCT03081858
What this trial is testing

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder Cancer+7 more
Lipac Oncology LLC 15
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Not applicableLooking for participantsNCT04564781
What this trial is testing

Predicting BCG Response

Who this might be right for
Bladder Cancer
Cedars-Sinai Medical Center 400
Not applicableNot Yet RecruitingNCT06880939
What this trial is testing

Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects

Who this might be right for
Urinary Bladder Neoplasms
Qilu Hospital of Shandong University 210
Large-scale testing (Phase 3)UnknownNCT04736394
What this trial is testing

Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Large-scale testing (Phase 3)UnknownNCT05490082
What this trial is testing

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

Who this might be right for
Voiding Disorders
Mansoura University 100
Testing effectiveness (Phase 2)Study completedNCT00595088
What this trial is testing

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Anchiano Therapeutics Israel Ltd. 47
Testing effectiveness (Phase 2)Looking for participantsNCT06635889
What this trial is testing

Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain

Who this might be right for
Nephrolithiasis
University of Chicago 116
Not applicableLooking for participantsNCT07048496
What this trial is testing

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Who this might be right for
Bladder Cancer
Abramson Cancer Center at Penn Medicine 50
Not applicableStudy completedNCT03689478
What this trial is testing

Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT

Who this might be right for
Bladder CancerHyperthermiaChemotherapy Effect
Chinese University of Hong Kong 30
Early research (Phase 1)Study completedNCT03519750
What this trial is testing

Pharmacokinetics of Intravenous, Rectal, Intravesical, Vaginal, and Transdermal Melatonin in Healthy Female Volunteers

Who this might be right for
MelatoninPharmacokineticsSafety
Dennis Bregner Zetner 10
Next Page